GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (XBRU:PFEBC) » Definitions » Cyclically Adjusted Book per Share

Pfizer (XBRU:PFEBC) Cyclically Adjusted Book per Share : €0.00 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Pfizer Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pfizer's adjusted book value per share for the three months ended in Dec. 2023 was €12.748. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Pfizer's average Cyclically Adjusted Book Growth Rate was 4.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 4.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pfizer was 27.40% per year. The lowest was 0.90% per year. And the median was 7.70% per year.

As of today (2024-05-03), Pfizer's current stock price is €21.65. Pfizer's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €0.00. Pfizer's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pfizer was 4.70. The lowest was 1.75. And the median was 2.87.


Pfizer Cyclically Adjusted Book per Share Historical Data

The historical data trend for Pfizer's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Cyclically Adjusted Book per Share Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pfizer Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pfizer's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, Pfizer's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Cyclically Adjusted PB Ratio falls into.



Pfizer Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pfizer's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=12.748/129.4194*129.4194
=12.748

Current CPI (Dec. 2023) = 129.4194.

Pfizer Quarterly Data

Book Value per Share CPI Adj_Book
201403 8.679 99.695 11.267
201406 8.749 100.560 11.260
201409 9.448 100.428 12.175
201412 9.027 99.070 11.792
201503 9.708 99.621 12.612
201506 9.305 100.684 11.961
201509 9.297 100.392 11.985
201512 9.275 99.792 12.029
201603 8.841 100.470 11.388
201606 8.721 101.688 11.099
201609 8.806 101.861 11.188
201612 8.812 101.863 11.196
201703 8.530 102.862 10.732
201706 8.110 103.349 10.156
201709 7.960 104.136 9.893
201712 9.408 104.011 11.706
201803 8.887 105.290 10.924
201806 9.326 106.317 11.353
201809 9.543 106.507 11.596
201812 8.702 105.998 10.625
201903 8.125 107.251 9.804
201906 8.231 108.070 9.857
201909 9.230 108.329 11.027
201912 8.873 108.420 10.592
202003 9.188 108.902 10.919
202006 8.922 108.767 10.616
202009 8.653 109.815 10.198
202012 8.118 109.897 9.560
202103 9.002 111.754 10.425
202106 9.079 114.631 10.250
202109 10.048 115.734 11.236
202112 10.670 117.630 11.739
202203 11.688 121.301 12.470
202206 12.884 125.017 13.338
202209 14.611 125.227 15.100
202212 14.103 125.222 14.576
202303 14.728 127.348 14.968
202306 14.274 128.729 14.351
202309 14.185 129.860 14.137
202312 12.748 129.419 12.748

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Pfizer  (XBRU:PFEBC) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pfizer was 4.70. The lowest was 1.75. And the median was 2.87.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pfizer Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Pfizer's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer (XBRU:PFEBC) Business Description

Industry
Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer (XBRU:PFEBC) Headlines

No Headlines